EP-1453: Analysis on research and cooperation status of heavy ion  by Tian, J. et al.
ESTRO 35 2016                                                                                                                                                    S673 
________________________________________________________________________________ 
more than their corresponding subsequent daily treatment 
times. Radiation oncologists need to be cognizant of these 
issues in everyday management of their patients. 
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Purpose or Objective: Integration of multiple technical 
aspects like treatment prescription, planning, delivery and 
quality assurance is paramount for smooth and efficient 
functioning of any radiotherapy department. In the 
developing world, bearing 60% of global cancer burden, 
efficient management of available resources assumes even 
greater importance. Workflow management software is a tool 
available for effective resource management in radiotherapy. 
The purpose of this audit is to evaluate the impact of 
implementation of workflow management on the 
organisational ergonomics of our department.  
 
Material and Methods: Workflow management software (Aria 
v 11.0™) has been in use in our department since October 
2014. Prior to that, on-paper documentation was the 
predominant mode of communication between physicians and 
physicists for all forms of conformal treatment planning. Case 
records of patients who were treated with conformal 
radiation in the two month period prior to and after the 
implementation of workflow management were 
retrospectively evaluated. Proportion of cases for which 
treatment was started on the day of appointment was taken 
as a surrogate for work efficiency, which was the primary end 
point in this study. Other variables, like time available for 
target delineation (Td), treatment planning (Tp) and plan 
evaluation (Te) were analysed for different conformal 
techniques as secondary end points. 
 
Results: Of the 343 cases analysed, 190 were treated before 
implementation of workflow management (group 1), while 
153 were treated after that (group 2). The mean gap 
between planning CT scans and date of treatment (overall 
planning time, To = Td + Tp + Te) was 5.25 days for group 1 
and 6.53 days for group 2 (p=0.104).  
Among 3D-CRT plans, 29% were not started on the day of 
appointment in group 1, while 20% were not started on time 
in group 2 (p= 0.13). However, mean time available for 
planning and evaluation (Tp + Te) increased from 1.3 days in 
group 1 to 2.8 days in group 2 (p<0.01), without significant 
increase in overall planning time (To). 
In group 1, 71% of IMRT plans were not started on time, while 
only 27.2% were not started on time in group 2 (p<0.0001). 
Overall planning time (To) for IMRT decreased from a mean 
of 9.4 days to 5.9 days, after workflow management 
(p=0.013), without significant compromise in the time 
available for planning and evaluation (Tp + Te). 
On multivariate analysis, workflow management was an 
independent factor determining work efficiency (p=0.04) 
irrespective of the diagnosis, physician or physicist. 
 
Conclusion: Implementation of workflow management 
resulted in significant improvement in work efficiency, as 
evidenced by an increase in proportion of cases started on 
time; this improvement was more substantial for IMRT 
planning. Time available for planning and evaluation also 
significantly increased with workflow management. Such 
improvements in work efficiency are essential for resource 
management in developing countries. 
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Purpose or Objective: Substantial variations exist in the use 
of mastectomy and breast-conserving surgery (BCS or 
lumpectomy) to treat invasive cancer. No recent analysis has 
queried the broader role of individual surgeons play in the 
decision making process for BCS or mastectomy. The goal of 
this study was to evaluate the impact of individual surgeons 
on surgical procedures for definitive treatment of breast 
cancer in a large cohort of Medicare beneficiaries. 
 
Material and Methods: 36,068 women with non-metastatic 
breast cancer undergoing primary surgery (either BCS or 
mastectomy) were identified from Surveillance, 
Epidemiology, and End Results-Medicare linked database from 
2000 to 2009. Medicare claims were used to determine 
surgery type and provider. Health service area stratified, 
multi-level, multivariable logistic models clustered by 
surgeon were used to determine the impact of surgeons on 
the likelihood of mastectomy while controlling for a patient’s 
clinical and demographic covariates.  
 
Results: 8,327 women were treated with mastectomy. 20.9% 
of the variation in the likelihood of mastectomy was due to 
the individual surgeon; 18.8% of this variation in surgery was 
due to a patient’s clinical and demographic status. The 
median odds ratio, which allows for a direct comparison 
between the effect of the cluster variable (surgeon) and the 
odds ratio (OR) of fixed covariates, was 2.43. The only 
variables with a greater impact than surgeon were regional 
lymph node surgery (OR 3.0, 95% confidence interval [CI]: 
2.79, 3.23) and primary tumor size 2-5 centimeters (OR 2.79, 
95% CI: 2.62, 2.97).  
 
Conclusion: Surgeons have a substantial impact on a 
woman’s likelihood of mastectomy for the treatment of 
invasive breast cancer. Further research should clarify the 
role of the patient in the decision making process. 
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Purpose or Objective: To analyze the status of research on 
heavy ion using the social network analysis methods and 
analytical methods bibliometric methods. 
 
Material and Methods: We searched PubMed database by 
(“heavy ion radiotherapies”[Title/Abstract] OR “heavy ion 
radiotherapy”[Title/Abstract] OR “heavy ion 
therapy”[Title/Abstract] OR “heavy ion 
therapies”[Title/Abstract] OR “heavy ion radiation 
therapies”[Title/Abstract] OR “heavy ion radiation 
therapy”[Title/Abstract] OR “carbon ion 
radiotherapies”[Title/Abstract] OR “carbon ion 
radiotherapy”[Title/Abstract] OR “carbon ion 
therapy”[Title/Abstract] OR “carbon ion 
therapies”[Title/Abstract] OR “carbon ion radiation 
therapies”[Title/Abstract] OR “carbon ion radiation 
therapy”[Title/Abstract] OR "Heavy Ion Radiotherapy"[Mesh]) 
OR ((“hellion ion”[Title/Abstract] OR “hellium 
ion”[Title/Abstract] OR neno[Title/Abstract] OR “carbon 
ion”[Title/Abstract] OR “carbon ions”[Title/Abstract]) AND 
(Radiotherapy[Title/Abstract] OR 
radiotherapies[Title/Abstract] OR “radiation therapy” 
[Title/Abstract] OR “radiation therapies” [Title/Abstract] OR 
("radiotherapy" [Subheading] OR "Radiotherapy"[Mesh])),to 
collect all relevant research on heavy ion. The related 
software was used to extract the information of author, 
country, year of publication, publication year,MeSH terms 
and journal name. SPSS17.0 was used to analyze the 
frequency and percentage. NetDraw software was used to 
draw the social network plot. 
 
Results: 907 studies were retrieved, The number of studies 
on heavy ion were increased from 1975 to 2014, the author 
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mainly came from Japan, Germany and China,the number of 
research on carbon ions were more than the number of 
research on neon ion and helium ion(Figure1); the published 
paper focused on the clinical research on the effectiveness of 
heavy ion for cancer,at the same time, heavy ions of 
animal,tumor cells and equipment design were also 
concered,30 kinds of tumor were researched.Cooperation 
degree of different researchers is not enough(Figure1). 
 
 
 
Conclusion: The number of research on heavy ion are 
increased, but there is an imbalance in regional 
development,the research topic focused on the clinical 
research and basic research topics,at the same time, the 
equipment and design of heavy ion are concered. 
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Purpose or Objective: To analyze the status of research on 
proton using the social network analysis methods and 
analytical methods bibliometric methods. 
 
Material and Methods: We searched PubMed and EMBASE 
database by “proton OR proton radiation OR proton beam 
therapy OR proton beam radiotherapy OR proton 
irradiation”,to collect all relevant research on proton. The 
related software was used to extract the information of 
author, country, year of publication, publication year,MeSH 
terms and journal name. SPSS17.0 was used to analyze the 
frequency and percentage. NetDraw software was used to 
draw the social network plot. 
 
Results: 2637 studies were retrieved, The number of studies 
on proton from one study in 1975 to 556 studies in 
2014.Figure shoewd the research in the global distribution.As 
for different parts of the tumor, mainly for urinary 
reproductive system tumor (n=349), soft tissue tumor (n=37), 
skin tumor (n=100), the reticular endothelial cell tumor 
(n=85), respiratory system tumor(n=232), pelvic tumors 
(n=10), nervous system tumors (n=531), thoracic and the 
chest tumor (n=15), the lymphatic system (n=85), the motor 
system tumor (n=150), the hematopoietic system 
tumor(n=14), head and neck cancer (n=269), digestive system 
tumors (n=318), cardiovascular system tumor (n=18), breast 
tumor (n=211), and abdominal tumor (n=12).As for benign 
tumors, mainly for epidermoid tumor, epidermoid cyst, 
ventricle meningioma, cystadenoma, dyeing neoplasia, 
choroid plexus papilloma, chondroma, cartilage tumor, 
cavernous hemangioma, inverted papilloma of the mammary 
gland, mammary gland fibroma and breast fibroadenoma, 
adenoma and acoustic neuroma.As for type of study, 
conference abstract (48.24%), conference paper (1.93%) 
,study (38.36%), review (7.61%), letter (1.22%) and comments 
(1.22%), editor's note (0.59%), short-term observation (1%), 
and conference review(1%). 
 
 
 
Conclusion: the number of studies on proton are 
increased,but the research in the global distribution is 
imbalance,many studies focuse on the nervous system tumor, 
urogenital system tumor and digestive system tumor.about 
50% published papers were conference abstract/paper. 
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Purpose or Objective: Workflow in radiotherapy involves a 
lot of different actors and different steps. Subsequently, the 
management of agendas, schedules and prioritization 
becomes difficult in a busy department. This results in delays 
and (first) sessions being delayed or cancelled without being 
able to be replaced. RT-Flow is a workflow optimization and 
visualization application (web based), supporting different 
workflows and clinical prioritization schemes. Our 
department works with both conventional retro scheduling 
and industry-based ConWip (management of a Constant Work-
In-Progress rather than agendas) workflow [1]. 
 
Material and Methods: RT-Flow was implemented in 2014 (3 
tomo's, 2 clinacs and 1 cyberknife). All evaluations were 
performed by year-to-year comparison: between 01/08 of 
2013, 2014 and 2015 (+-2500 patients/year). All numbers 
have been normalized to worked days, excluding breakdowns, 
holidays and maintenances for fair comparison. Productivity 
gain was evaluated for the following parameters: machine 
occupancy and number of first treatment sessions being 
delayed. Time between CT and prescription finalization has 
been evaluated before and after implementation of RT-Flow. 
 
 
 
Results: Total machine utilization (fractions per worked day, 
excluding maintenances and failures) rose with >2% in 
saturated machine conditions. The number of delayed first 
sessions (all 6 machines combined, all reasons confounded) 
was halved from 23.6/month to 12.2/month. This was an 
indirect gain of productivity, as the time slot was most of the 
time not recovered from late delays. For the specific ConWIP 
organized Cyberknife, machine utilization raised with 6% (on 
top of the earlier 30% increase due to the ConWIP 
organization [1]). This increase was due to the better specific 
workflow and occupation management by RT-Flow, but also 
due to a slight change in case mix (3% less liver treatments 
for example). Mean time between CT and prescription 
